BIIB vs IMMR · P/E 21, rev $9.89B vs rev $1.73B
Biogen Inc (BIIB) versus Immersion Corporation (IMMR) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Immersion Corporation (IMMR) is a software - application company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported IMMR revenue for 2026-04-30 was $1.73B. Net income was $4.5M. Revenue was up 11.2% from 2025-04-30 to 2026-04-30. IMMR currently screens at market cap $216.5M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. IMMR currently screens at market cap $216.5M.
Not investment advice. Open the BIIB and IMMR stock pages for the full models.
Not investment advice.